Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets

YK Tham, BC Bernardo, JYY Ooi, KL Weeks… - Archives of …, 2015 - Springer
The onset of heart failure is typically preceded by cardiac hypertrophy, a response of the
heart to increased workload, a cardiac insult such as a heart attack or genetic mutation …

Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways

K Huynh, BC Bernardo, JR McMullen… - Pharmacology & …, 2014 - Elsevier
Cardiovascular disease is the primary cause of morbidity and mortality among the diabetic
population. Both experimental and clinical evidence suggest that diabetic subjects are …

Protein kinase C, an elusive therapeutic target?

D Mochly-Rosen, K Das, KV Grimes - Nature reviews Drug discovery, 2012 - nature.com
Protein kinase C (PKC) has been a tantalizing target for drug discovery ever since it was first
identified as the receptor for the tumour promoter phorbol ester in 1982. Although initial …

Signaling effectors underlying pathologic growth and remodeling of the heart

JH Van Berlo, M Maillet… - The Journal of clinical …, 2013 - Am Soc Clin Investig
Cardiovascular disease is the number one cause of mortality in the Western world. The heart
responds to many cardiopathological conditions with hypertrophic growth by enlarging …

The role of PKC-MAPK signalling pathways in the development of hyperglycemia-induced cardiovascular complications

FF Jubaidi, S Zainalabidin, IS Taib… - International Journal of …, 2022 - mdpi.com
Cardiovascular disease is the most common cause of death among diabetic patients
worldwide. Hence, cardiovascular wellbeing in diabetic patients requires utmost importance …

IRS proteins and diabetic complications

DP Lavin, MF White, DP Brazil - Diabetologia, 2016 - Springer
IRS proteins are cellular adaptor molecules that mediate many of the key metabolic actions
of insulin. When tyrosine is phosphorylated by the activated insulin receptor, IRS proteins …

Involvement of circRNAs in the Development of Heart Failure

G Sygitowicz, D Sitkiewicz - International Journal of Molecular Sciences, 2022 - mdpi.com
In recent years, interest in non-coding RNAs as important physiological regulators has
grown significantly. Their participation in the pathophysiology of cardiovascular diseases is …

[HTML][HTML] PKC and PKN in heart disease

V Marrocco, J Bogomolovas, E Ehler… - Journal of molecular …, 2019 - ncbi.nlm.nih.gov
The protein kinase C (PKC) and closely related protein kinase N (PKN) families of
serine/threonine protein kinases play crucial cellular roles. Both kinases belong to the AGC …

Common mechanisms of Alzheimer's disease and ischemic stroke: the role of protein kinase C in the progression of age-related neurodegeneration

BP Lucke-Wold, RC Turner… - Journal of …, 2015 - content.iospress.com
Ischemic stroke and Alzheimer's disease (AD), despite being distinct disease entities, share
numerous pathophysiological mechanisms such as those mediated by inflammation …

[HTML][HTML] Microarray expression profile of circular RNAs in heart tissue of mice with myocardial infarction-induced heart failure

HJ Wu, CY Zhang, S Zhang, M Chang… - Cellular Physiology and …, 2016 - karger.com
Background/Aims: Myocardial infarction (MI) is a serious complication of atherosclerosis
associated with increasing mortality attributable to heart failure. This study is aimed to …